Reducing levels of nicotinic alkaloids in plants

US10085478B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10085478-B2
Application numberUS-201715828868-A
CountryUS
Kind codeB2
Filing dateDec 1, 2017
Priority dateFeb 28, 2005
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.

First claim

Opening claim text (preview).

What is claimed is: 1. A tobacco plant produced by a method comprising: (a) mutagenizing a plurality of tobacco plant cells to comprise one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 3, thereby producing a plurality of mutagenized cells comprising the one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 3; (b) screening plants generated from the mutagenized cells comprising the one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 3 for reduced expression of NBB1; and (c) selecting one or more of the progeny comprising the one or more mutations in the nucleotide sequence set forth in SEQ ID NO: 3, wherein the progeny has reduced NBB1 expression and reduced nicotine content as compared to a control tobacco plant, thereby resulting in a tobacco plant having reduced NBB1 expression and reduced nicotine content as compared to a control tobacco plant. 2. A tobacco product produced from the tobacco plant of claim 1 , wherein: (a) the tobacco product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, snus, pipe tobacco, and chewing tobacco, and (b) the tobacco product comprises the mutagenized cells of claim 1 . 3. A product produced from the tobacco plant of claim 1 , wherein: (a) the product is selected from the group consisting of a food product, food ingredient, feed product, feed ingredient, nutritional supplement, and biofuel, and (b) the product comprises the mutagenized cells of claim 1 .

Assignees

Inventors

Classifications

  • Plant cells or tissues {(culture media C12N5/0025)} · CPC title

  • Cigars; Cigarettes · CPC title

  • Polymorphic or mutational markers · CPC title

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10085478B2 cover?
Two genes, A622 and NBB1, can be influenced to achieve a decrease of nicotinic alkaloid levels in plants. In particular, suppression of one or both of A622 and NBB1 may be used to decrease nicotine in tobacco plants.
Who is the assignee on this patent?
22Nd Century Ltd Llc
What technology area does this patent fall under?
Primary CPC classification C12N15/8243. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).